Journal: Oncology Letters
Article Title: Proliferative escalation and possible neuroendocrine carcinoma transformation in pulmonary metastases of a cervical neuroendocrine tumor: A case report
doi: 10.3892/ol.2026.15501
Figure Lengend Snippet: Histopathological and immunohistochemical findings of the cervical tumor. (A) H&E staining (ocular, ×10; objective, ×4; final magnification, ×40) showing mixed histology. (B) H&E staining (ocular, ×10; objective, ×10; final magnification, ×100) revealing coexistence of adenocarcinoma and neuroendocrine components. (C) H&E staining of the neuroendocrine component (ocular, ×10; objective, ×40; final magnification, ×400). (D-L) Immunohistochemical analysis of the neuroendocrine component (ocular, ×10; objective, ×40; final magnification, ×400) revealing the following: (D) Synaptophysin, positive; (E) chromogranin A, positive; (F) p16, positive; (G) yes-associated protein 1, negative; (H) thyroid transcription factor-1, negative; (I) retinoblastoma protein, wild-type expression; (J) paired box 8, negative; (K) Ki-67, low proliferative activity; and (L) Ki-67, hotspot with high proliferative activity.
Article Snippet: The primary antibodies used for the immunostaining shown in and were as follows: synaptophysin (catalog no. 413831, clone 27G12; Nichirei Biosciences), chromogranin A (catalog no. M086901-2, clone DAK-A3; DAKO), p16 (catalog no. 550834, clone G175-405; BD Biosciences), YAP1 (catalog no. ab52771, clone EPR1674Y; Abcam), TTF-1 (catalog no. NCL-L-TTF-1, clone SPT24; NOVO), retinoblastoma protein (Rb; catalog no. 554136, clone G3-245; BD Biosciences), PAX8 (catalog no. ab53490, clone PAX8R1; abcam), and Ki-67 (catalog no. M7240, clone MIB-1; DAKO).
Techniques: Immunohistochemical staining, Staining, Expressing, Activity Assay